Eurofins’ stock price jumped >10% today as its H1 performance and upgraded FY2021 guidance was ahead of market expectations. The core offerings continued to accelerate with the relaxation of restrictions in Q2, while COVID-19-related revenue subsided sequentially. EBITDA margin benefited from accretive COVID-19 volumes and improved utilisation of start-up laboratories. We will raise our financial estimates and target price. However, we will retain our cautious recommendation; also pinned down by ....
05 Aug 2021
Riding high
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Riding high
- Published:
05 Aug 2021 -
Author:
Vansh Mehta -
Pages:
3
Eurofins’ stock price jumped >10% today as its H1 performance and upgraded FY2021 guidance was ahead of market expectations. The core offerings continued to accelerate with the relaxation of restrictions in Q2, while COVID-19-related revenue subsided sequentially. EBITDA margin benefited from accretive COVID-19 volumes and improved utilisation of start-up laboratories. We will raise our financial estimates and target price. However, we will retain our cautious recommendation; also pinned down by ....